Clinical Trials Directory

Trials / Completed

CompletedNCT00793000

Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults

A Phase 1 Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04287881 After First Time Administration Of Ascending Single Oral Doses To Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of PF-04287881 after a single oral dose in healthy adult volunteers.

Conditions

Interventions

TypeNameDescription
DRUGPF-0428788175 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 75 mg oral dose (prepared solution), given once
DRUGPF-04287881150 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 150 mg oral dose (prepared solution), given once
DRUGPF-04287881300 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 300 mg oral dose (prepared solution), given once
DRUGPF-04287881750 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 750 mg oral dose (prepared solution), given once
DRUGPF-042878811000 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 1000 mg oral dose (prepared solution), given once
DRUGPF-042878811250 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 1250 mg oral dose (prepared solution), given once
DRUGPF-042878811500 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 1500 mg oral dose (prepared solution), given once
DRUGPF-04287881300 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 300 mg oral dose (prepared solution), given once
DRUGPF-04287881750 mg oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 750 mg oral dose (prepared solution), given once
DRUGPF-042878811000 mg based on safety and PK from previous cohorts; oral dose (prepared solution) given once
DRUGPlaceboplacebo to match 1000 mg oral dose (prepared solution), given once

Timeline

Start date
2008-11-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-11-18
Last updated
2011-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00793000. Inclusion in this directory is not an endorsement.